How do we transform cervical cancer screening for the transgender population?
Dr Alison May Berner is a Specialist Trainee and Academic Clinical Fellow in Medical Oncology and part-time Speciality Registrar in Gender Medicine at Barts Cancer […]
Dr Alison May Berner is a Specialist Trainee and Academic Clinical Fellow in Medical Oncology and part-time Speciality Registrar in Gender Medicine at Barts Cancer […]
Our “Five Minutes With” series seeks to discover what are the habits, inspirations and obstacles that have shaped the careers of leading cancer researchers and […]
In this blog, we speak to Dr Maribel Almonte Pacheco, Prevention and Implementation Group Head at IARC. Dr Almonte is the chief investigator on the […]
The earliest stage of cervical cancer (known as micro-invasive or stage IA) is treated with minimally-invasive fertility-preserving surgery, often as an outpatient. In fact, very […]
To coincide with Cervical Cancer Prevention Week, Jo Waller (@Jo_WallerKCL) has pulled together a summary of the research our group has been doing over the […]
Changing burdens of disease When we discuss the burden of disease in regions such as Sub-Saharan Africa (SSA), our mind immediately jumps to examples such […]
Dr Anita Lim tells us how her team’s research is building the evidence-base for introducing cervical screening self-testing in England, along with other approaches to […]
Women around the world attend cervical screening regularly during most of their adult life, but in most countries, they are not encouraged to continue once […]
After months of eager anticipation, the results from the English HPV implementation pilot have been published. Compared to current screening HPV testing detected 50% more […]
In this post, Peter Sasieni argues that sensitivity is over-rated. It is the first of a series of posts on “Screening Iconoclasm” in which we […]
Copyright © 2024 | WordPress Theme by MH Themes